Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dynavax

10.24
+0.29002.91%
Post-market: 10.300.0600+0.59%19:09 EDT
Volume:1.41M
Turnover:14.32M
Market Cap:1.23B
PE:-21.83
High:10.25
Open:10.09
Low:10.00
Close:9.95
Loading ...

BRIEF-Dynavax Technologies Q1 Net Income USD -96.099 Million

Reuters
·
07 May

Dynavax Technologies Q1 EPS USD -0.77

THOMSON REUTERS
·
07 May

Dynavax Technologies Corp - Reaffirming FY2025 Financial Guidance

THOMSON REUTERS
·
07 May

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

PR Newswire
·
29 Apr

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

PR Newswire
·
23 Apr

BRIEF-Deep Track Capital Urges Dynavax Technologies Corp Shareholders To Vote For Deep Track's Four Highly Qualified Director Nominees

Reuters
·
22 Apr

Deep Track Capital: Urges Dynavax Technologies Corp Shareholders to Vote for Deep Track's Four Highly Qualified Director Nominees

THOMSON REUTERS
·
22 Apr

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Business Wire
·
22 Apr

Dynavax Is Maintained at Sell by Goldman Sachs

Dow Jones
·
18 Apr

BRIEF-Dynavax Technologies Corp - Urges Stockholders To Vote 'For' All Four Co's Director Nominees

Reuters
·
17 Apr

Dynavax Technologies Corp - Urges Stockholders to Vote 'for' All Four Co's Director Nominees

THOMSON REUTERS
·
17 Apr

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

PR Newswire
·
17 Apr

Dynavax, Deep Track Capital Step Up Fight Ahead of June 11 Annual Meeting

MT Newswires Live
·
17 Apr

DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up

Zacks
·
16 Apr

Deep Track: Dynavax Technologies' Board Rejects Nomination of Four Candidates to Its Board

THOMSON REUTERS
·
16 Apr

PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose

Zacks
·
10 Apr

PCRX Stock Soars on Exparel Patent Settlement With Generic Players

Zacks
·
08 Apr

RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study

Zacks
·
08 Apr

Dynavax Technologies (NASDAQ:DVAX) pulls back 3.7% this week, but still delivers shareholders massive 32% CAGR over 5 years

Simply Wall St.
·
08 Apr

AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs

Zacks
·
07 Apr